Medicina - Xagena Medicina. Xagena.it fornisce informazioni e aggiornamenti sulle Patologie e sulla Terapia medica. Focus su Nuove Terapie per i Tumori.

Metastatic colorectal cancer: better surgical interventions, new chemotherapeutic and biological agents increase 5-year survival from 8 to 30 percent.

Stable coronary artery disease, FDA approves Aceon to reduce risk of cardiovascular mortality or non-fatal myocardial infarction ... FDA ( Food and Drug ...

The trials pair the oral drugs Lenalidomide and Dexamethasone with other agents, each of which exploits a different vulnerability in tumor cells. The various ...

In addition, they tested a genetically engineered virus to deliver two proteins directly to the brain. The findings are reported in the journal Cancer Research.

" Researchers and clinicians can use it to reduce the expression of the target gene in a single or limited numbers of cell types or tissues, thereby reducing ...

The Phase 2 clinical trial has also found that AZD2171 treatment can alleviate brain swelling ( edema ), a debilitating symptom in many brain cancer patients ...

The endocannabinoid system was discovered through research into delta 9 –tetrahydrocannabinol ( THC ), the active ingredient in cannabis.

Novartis has a comprehensive portfolio of cardiovascular products both in the market ( Diovan and Lotrel ) as well as in development ( such as LAF237 and SPP ...

The FDA designated Gamunex as an orphan drug to treat CIDP. Chronic inflammatory demyelinating polyneuropathy, which affects about 25,000 people in the United ...